https://www.news-medical.net/news/20090802/FDA-approves-Onglyza-(saxagliptin)-for-type-2-diabetes.aspx
FDA approves Onglyza (saxagliptin) for type 2 diabetes
Jun 24, 2019 - The U.S. Food and Drug Administration has approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to...
fda approvesonglyzasaxagliptintypediabetes